Skip to main content

Advertisement

SpringerLink
Log in

Correspondence

Reduced-intensity allogeneic stem cell transplantation as salvage treatment for patients with indolent lymphoma or CLL after failure of autologous SCT

  • Original Article
  • Published:
Bone Marrow Transplantation Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

References

  1. Voso MT, Martin S, Hohaus S . Prognostic factors for the clinical outcome of patients with follicular lymphoma following high-dose therapy and peripheral blood stem cell transplantation (PBSCT) Bone Marrow Transplant 2000 25: 957–964

    Article  CAS  Google Scholar 

  2. Dreger P, Martin S, Kuse R . The impact of autologous stem cell transplantation on the prognosis of mantle cell lymphoma: a joint analysis of two prospective studies with 46 patients The Hematology Journal 2000 1: 87–94

    Article  CAS  Google Scholar 

  3. van Besien K, Sobocinski KA, Rowlings PA . Allogeneic bone marrow transplantation for low-grade lymphoma Blood 1998 92: 1832–1836

    CAS  PubMed  Google Scholar 

  4. Khouri I, Lee M-S, Palmer JL . Transplant-lite using fludarabine-cyclophosphamide and allogeneic stem cell transplant for low-grade lymphoma Blood 2000 94: (Suppl.1) 348a (Abstr.)

    Google Scholar 

  5. Nagler A, Slavin S, Varadi G . Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma Bone Marrow Transplant 2000 25: 1021–1028

    Article  CAS  Google Scholar 

  6. Dreger P, Viehmann K, von Neuhoff N . A prospective study of positive/negative ex vivo B cell depletion in patients with chronic lymphocytic leukemia Exp Hematol 2000 28: 1187–1196

    Article  CAS  Google Scholar 

  7. Kottaridis P, Chakraverty R, Milligan DW . A non-myeloablative regimen for allogeneic stem cell transplantation with a low incidence of GVHD Bone Marrow Transplant 2000 25: (Suppl.1) S26 (Abstr.)

    Article  Google Scholar 

  8. Cull GM, Haynes AP, Byrne JL . Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH conditioning: an effective regimen with low procedure-related toxicity Br J Haematol 2000 108: 754–760

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Internal Medicine II and BMT Unit, University of Kiel, Chemnitzstr 33, Kiel, 24116, Germany

    P Dreger, B Glass, B Seyfarth, A Humpe, A Claviez, N von Neuhoff, M Suttorp, R Schoch & N Schmitz

Authors
  1. P Dreger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B Glass
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B Seyfarth
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A Humpe
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A Claviez
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. N von Neuhoff
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M Suttorp
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. R Schoch
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. N Schmitz
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dreger, P., Glass, B., Seyfarth, B. et al. Reduced-intensity allogeneic stem cell transplantation as salvage treatment for patients with indolent lymphoma or CLL after failure of autologous SCT. Bone Marrow Transplant 26, 1361–1362 (2000). https://doi.org/10.1038/sj.bmt.1702722

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702722

  • Springer Nature Limited

This article is cited by

Search

Navigation